Ember Therapeutics, Inc. — Form D
Ember Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-12-21. The offering totals $34.2M, of which $3.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-12-21
- Form: D
- Accession: 0001537900-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $34.2M
- Amount sold: $3.2M
- Remaining: $31.0M
- Investors: 1
- Date of first sale: 2011-12-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-170448
Issuer
- Name: Ember Therapeutics, Inc.
- CIK: 0001537900
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 29 NEWBURY ST, BOSTON, MA, 02116
- Phone: 617-585-2079
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Dan Lynch | Director | Boston, MA |
| Bruce Spiegelman | Director | Boston, MA |
| Louis Tartaglia | Director | BOSTON, MA |
| Mitchell Bloom | Executive Officer | Boston, MA |
| Kevin Gillis | Executive Officer | Boston, MA |
| Louis Tartaglia | Executive Officer | BOSTON, MA |
More